Normal view MARC view ISBD view

How would you like your tea, vicar? [electronic resource]

By:

Jamnadas-Khoda, Benjamin

Contributor(s):

Producer: 20101019Description: 356-9 p. digitalISSN:

1879-1409

Subject(s):

Online resources:

Available from publisher's website

In: Burns : journal of the International Society for Burn Injuries vol. 36

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

221 Particle Therapy at the "Tipping Point": An Introduction to the Red Journal's Special Edition.
by Zietman, Anthony L
222 Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra®) dosing in patients with primary immunodeficiency.
by Zhang, Ying
223 FDA perspective on specifications for biotechnology products--from IND to PLA.
by Murano, G
224 [New era in cancer therapy. Gefitinib: small molecule--strong action].
by Arnheim, Katharina
225 The diverse ethics of translational research.
by Sofaer, Neema
226 Substantiating the concerns about recombinant human activated protein C use in sepsis.
by Deans, Katherine J
227 Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis.
by Sudarshan, M K
228 How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
by Binzak, Barbara Ann
229 Real-life dosing with second-generation antipsychotics.
by Correll, Christoph U
230 Moxifloxacin safety: an analysis of 14 years of clinical data.
by Tulkens, Paul M
231 PCSK9 inhibitors: a non-statin cholesterol-lowering treatment option.
by Pokrywka, Gregory S
232 The potential impact of palivizumab on pediatric airway reconstruction.
by Emerick, Kevin
233 The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
by Messina, Silvia
234 Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.
by Moots, Robert J
235 "How much do you get paid if I volunteer?" Suggested institutional policy on reward, consent, and research.
by La Puma, J
236 Treatment of asphyxiated newborns with moderate hypothermia in routine clinical practice: how cooling is managed in the UK outside a clinical trial.
by Azzopardi, D
237 Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical setting.
by Vender, Ronald
238 Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
by Bhambri, Rahul
239 ISAR-REACT 5 - What have we learned?
by Kubica, Jacek
240 Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
by Chan, Yi-Hsin